MacroGenics | MGNX - Loan Capital


MacroGenics reported $68.71M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 64.53B 5.59B Mar/2026
Amgen USD 51.86B 27M Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Biogen USD 7.29B 1B Jun/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Daiichi Sankyo JPY 500B 199.92B Jun/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Genmab DKK 4.96B 28M Jun/2026
Geron USD 120.13M 298K Jun/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
J&J USD 37.34B 183M Jun/2026
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
MacroGenics USD 68.71M 1.29M Mar/2026
Merck USD 51.08B 4.41B Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Xencor USD 77.54M 4.59M Jun/2026